The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Biologic Therapeutics Drugs Market Research Report 2022

Global Biologic Therapeutics Drugs Market Research Report 2022

Publishing Date : Jul, 2022

License Type :
 

Report Code : 1413793

No of Pages : 96

Synopsis
Due to the COVID-19 pandemic, the global Biologic Therapeutics Drugs market size is estimated to be worth US$ 322420 million in 2021 and is forecast to a readjusted size of US$ 487360 million by 2028 with a CAGR of 6.0% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Biologic Therapeutics Drugs market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Biologic Therapeutics Drugs landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins.

This report focuses on Biologic Therapeutics Drugs volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Biologic Therapeutics Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Global Biologic Therapeutics Drugs Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

  • Avian Cell Culture
  • Yeast
  • Bacteria
  • Insects Cell Culture
  • Transgenics

Segment by Application

  • Rheumatoid Arthritis
  • Anemia
  • Cancer
  • Diabetes
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

By Company

  • Pfizer
  • AstraZeneca
  • Novartis
  • Merck
  • Smith Medical
  • GlaxoSmithKline
  • Concord Biotech
  • Aurobindo Pharma
  • H. Lundbeck
  • Retractable Technologies
Index

1 Biologic Therapeutics Drugs Market Overview
1.1 Product Overview and Scope of Biologic Therapeutics Drugs
1.2 Biologic Therapeutics Drugs Segment by Type
1.2.1 Global Biologic Therapeutics Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Avian Cell Culture
1.2.3 Yeast
1.2.4 Bacteria
1.2.5 Insects Cell Culture
1.2.6 Transgenics
1.3 Biologic Therapeutics Drugs Segment by Application
1.3.1 Global Biologic Therapeutics Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Rheumatoid Arthritis
1.3.3 Anemia
1.3.4 Cancer
1.3.5 Diabetes
1.3.6 Others
1.4 Global Biologic Therapeutics Drugs Market Size Estimates and Forecasts
1.4.1 Global Biologic Therapeutics Drugs Revenue 2017-2028
1.4.2 Global Biologic Therapeutics Drugs Sales 2017-2028
1.4.3 Biologic Therapeutics Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Biologic Therapeutics Drugs Market Competition by Manufacturers
2.1 Global Biologic Therapeutics Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Biologic Therapeutics Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Biologic Therapeutics Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Biologic Therapeutics Drugs Manufacturing Sites, Area Served, Product Type
2.5 Biologic Therapeutics Drugs Market Competitive Situation and Trends
2.5.1 Biologic Therapeutics Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Biologic Therapeutics Drugs Players Market Share by Revenue
2.5.3 Global Biologic Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biologic Therapeutics Drugs Retrospective Market Scenario by Region
3.1 Global Biologic Therapeutics Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Biologic Therapeutics Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Biologic Therapeutics Drugs Market Facts & Figures by Country
3.3.1 North America Biologic Therapeutics Drugs Sales by Country
3.3.2 North America Biologic Therapeutics Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Biologic Therapeutics Drugs Market Facts & Figures by Country
3.4.1 Europe Biologic Therapeutics Drugs Sales by Country
3.4.2 Europe Biologic Therapeutics Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Biologic Therapeutics Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Biologic Therapeutics Drugs Sales by Region
3.5.2 Asia Pacific Biologic Therapeutics Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Biologic Therapeutics Drugs Market Facts & Figures by Country
3.6.1 Latin America Biologic Therapeutics Drugs Sales by Country
3.6.2 Latin America Biologic Therapeutics Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Biologic Therapeutics Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Biologic Therapeutics Drugs Sales by Country
3.7.2 Middle East and Africa Biologic Therapeutics Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Biologic Therapeutics Drugs Historic Market Analysis by Type
4.1 Global Biologic Therapeutics Drugs Sales Market Share by Type (2017-2022)
4.2 Global Biologic Therapeutics Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Biologic Therapeutics Drugs Price by Type (2017-2022)
5 Global Biologic Therapeutics Drugs Historic Market Analysis by Application
5.1 Global Biologic Therapeutics Drugs Sales Market Share by Application (2017-2022)
5.2 Global Biologic Therapeutics Drugs Revenue Market Share by Application (2017-2022)
5.3 Global Biologic Therapeutics Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Pfizer Biologic Therapeutics Drugs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 AstraZeneca Biologic Therapeutics Drugs Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Novartis Biologic Therapeutics Drugs Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Merck Biologic Therapeutics Drugs Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Smith Medical
6.5.1 Smith Medical Corporation Information
6.5.2 Smith Medical Description and Business Overview
6.5.3 Smith Medical Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Smith Medical Biologic Therapeutics Drugs Product Portfolio
6.5.5 Smith Medical Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 GlaxoSmithKline Biologic Therapeutics Drugs Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Concord Biotech
6.6.1 Concord Biotech Corporation Information
6.6.2 Concord Biotech Description and Business Overview
6.6.3 Concord Biotech Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Concord Biotech Biologic Therapeutics Drugs Product Portfolio
6.7.5 Concord Biotech Recent Developments/Updates
6.8 Aurobindo Pharma
6.8.1 Aurobindo Pharma Corporation Information
6.8.2 Aurobindo Pharma Description and Business Overview
6.8.3 Aurobindo Pharma Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Aurobindo Pharma Biologic Therapeutics Drugs Product Portfolio
6.8.5 Aurobindo Pharma Recent Developments/Updates
6.9 H. Lundbeck
6.9.1 H. Lundbeck Corporation Information
6.9.2 H. Lundbeck Description and Business Overview
6.9.3 H. Lundbeck Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 H. Lundbeck Biologic Therapeutics Drugs Product Portfolio
6.9.5 H. Lundbeck Recent Developments/Updates
6.10 Retractable Technologies
6.10.1 Retractable Technologies Corporation Information
6.10.2 Retractable Technologies Description and Business Overview
6.10.3 Retractable Technologies Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Retractable Technologies Biologic Therapeutics Drugs Product Portfolio
6.10.5 Retractable Technologies Recent Developments/Updates
7 Biologic Therapeutics Drugs Manufacturing Cost Analysis
7.1 Biologic Therapeutics Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Biologic Therapeutics Drugs
7.4 Biologic Therapeutics Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Biologic Therapeutics Drugs Distributors List
8.3 Biologic Therapeutics Drugs Customers
9 Biologic Therapeutics Drugs Market Dynamics
9.1 Biologic Therapeutics Drugs Industry Trends
9.2 Biologic Therapeutics Drugs Market Drivers
9.3 Biologic Therapeutics Drugs Market Challenges
9.4 Biologic Therapeutics Drugs Market Restraints
10 Global Market Forecast
10.1 Biologic Therapeutics Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Biologic Therapeutics Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Biologic Therapeutics Drugs by Type (2023-2028)
10.2 Biologic Therapeutics Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Biologic Therapeutics Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Biologic Therapeutics Drugs by Application (2023-2028)
10.3 Biologic Therapeutics Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Biologic Therapeutics Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Biologic Therapeutics Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Biologic Therapeutics Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Biologic Therapeutics Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Biologic Therapeutics Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Biologic Therapeutics Drugs Market Competitive Situation by Manufacturers in 2021
Table 5. Global Biologic Therapeutics Drugs Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Biologic Therapeutics Drugs Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Biologic Therapeutics Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Biologic Therapeutics Drugs Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Biologic Therapeutics Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Biologic Therapeutics Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Biologic Therapeutics Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Biologic Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologic Therapeutics Drugs as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Biologic Therapeutics Drugs Sales by Region (2017-2022) & (K Units)
Table 16. Global Biologic Therapeutics Drugs Sales Market Share by Region (2017-2022)
Table 17. Global Biologic Therapeutics Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Biologic Therapeutics Drugs Revenue Market Share by Region (2017-2022)
Table 19. North America Biologic Therapeutics Drugs Sales by Country (2017-2022) & (K Units)
Table 20. North America Biologic Therapeutics Drugs Sales Market Share by Country (2017-2022)
Table 21. North America Biologic Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Biologic Therapeutics Drugs Revenue Market Share by Country (2017-2022)
Table 23. Europe Biologic Therapeutics Drugs Sales by Country (2017-2022) & (K Units)
Table 24. Europe Biologic Therapeutics Drugs Sales Market Share by Country (2017-2022)
Table 25. Europe Biologic Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Biologic Therapeutics Drugs Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Biologic Therapeutics Drugs Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Biologic Therapeutics Drugs Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Biologic Therapeutics Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Biologic Therapeutics Drugs Revenue Market Share by Region (2017-2022)
Table 31. Latin America Biologic Therapeutics Drugs Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Biologic Therapeutics Drugs Sales Market Share by Country (2017-2022)
Table 33. Latin America Biologic Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Biologic Therapeutics Drugs Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Biologic Therapeutics Drugs Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Biologic Therapeutics Drugs Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Biologic Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Biologic Therapeutics Drugs Revenue Market Share by Country (2017-2022)
Table 39. Global Biologic Therapeutics Drugs Sales by Type (2017-2022) & (K Units)
Table 40. Global Biologic Therapeutics Drugs Sales Market Share by Type (2017-2022)
Table 41. Global Biologic Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Biologic Therapeutics Drugs Revenue Share by Type (2017-2022)
Table 43. Global Biologic Therapeutics Drugs Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Biologic Therapeutics Drugs Sales (K Units) by Application (2017-2022)
Table 45. Global Biologic Therapeutics Drugs Sales Market Share by Application (2017-2022)
Table 46. Global Biologic Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Biologic Therapeutics Drugs Revenue Share by Application (2017-2022)
Table 48. Global Biologic Therapeutics Drugs Price by Application (2017-2022) & (USD/Unit)
Table 49. Pfizer Corporation Information
Table 50. Pfizer Description and Business Overview
Table 51. Pfizer Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. Pfizer Biologic Therapeutics Drugs Product
Table 53. Pfizer Recent Developments/Updates
Table 54. AstraZeneca Corporation Information
Table 55. AstraZeneca Description and Business Overview
Table 56. AstraZeneca Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. AstraZeneca Biologic Therapeutics Drugs Product
Table 58. AstraZeneca Recent Developments/Updates
Table 59. Novartis Corporation Information
Table 60. Novartis Description and Business Overview
Table 61. Novartis Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Novartis Biologic Therapeutics Drugs Product
Table 63. Novartis Recent Developments/Updates
Table 64. Merck Corporation Information
Table 65. Merck Description and Business Overview
Table 66. Merck Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Merck Biologic Therapeutics Drugs Product
Table 68. Merck Recent Developments/Updates
Table 69. Smith Medical Corporation Information
Table 70. Smith Medical Description and Business Overview
Table 71. Smith Medical Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Smith Medical Biologic Therapeutics Drugs Product
Table 73. Smith Medical Recent Developments/Updates
Table 74. GlaxoSmithKline Corporation Information
Table 75. GlaxoSmithKline Description and Business Overview
Table 76. GlaxoSmithKline Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. GlaxoSmithKline Biologic Therapeutics Drugs Product
Table 78. GlaxoSmithKline Recent Developments/Updates
Table 79. Concord Biotech Corporation Information
Table 80. Concord Biotech Description and Business Overview
Table 81. Concord Biotech Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Concord Biotech Biologic Therapeutics Drugs Product
Table 83. Concord Biotech Recent Developments/Updates
Table 84. Aurobindo Pharma Corporation Information
Table 85. Aurobindo Pharma Description and Business Overview
Table 86. Aurobindo Pharma Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Aurobindo Pharma Biologic Therapeutics Drugs Product
Table 88. Aurobindo Pharma Recent Developments/Updates
Table 89. H. Lundbeck Corporation Information
Table 90. H. Lundbeck Description and Business Overview
Table 91. H. Lundbeck Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. H. Lundbeck Biologic Therapeutics Drugs Product
Table 93. H. Lundbeck Recent Developments/Updates
Table 94. Retractable Technologies Corporation Information
Table 95. Retractable Technologies Description and Business Overview
Table 96. Retractable Technologies Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Retractable Technologies Biologic Therapeutics Drugs Product
Table 98. Retractable Technologies Recent Developments/Updates
Table 99. Production Base and Market Concentration Rate of Raw Material
Table 100. Key Suppliers of Raw Materials
Table 101. Biologic Therapeutics Drugs Distributors List
Table 102. Biologic Therapeutics Drugs Customers List
Table 103. Biologic Therapeutics Drugs Market Trends
Table 104. Biologic Therapeutics Drugs Market Drivers
Table 105. Biologic Therapeutics Drugs Market Challenges
Table 106. Biologic Therapeutics Drugs Market Restraints
Table 107. Global Biologic Therapeutics Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 108. Global Biologic Therapeutics Drugs Sales Market Share Forecast by Type (2023-2028)
Table 109. Global Biologic Therapeutics Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 110. Global Biologic Therapeutics Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 111. Global Biologic Therapeutics Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 112. Global Biologic Therapeutics Drugs Sales Market Share Forecast by Application (2023-2028)
Table 113. Global Biologic Therapeutics Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 114. Global Biologic Therapeutics Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 115. Global Biologic Therapeutics Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 116. Global Biologic Therapeutics Drugs Sales Market Share Forecast by Region (2023-2028)
Table 117. Global Biologic Therapeutics Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 118. Global Biologic Therapeutics Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Biologic Therapeutics Drugs
Figure 2. Global Biologic Therapeutics Drugs Market Share by Type in 2021 & 2028
Figure 3. Avian Cell Culture Product Picture
Figure 4. Yeast Product Picture
Figure 5. Bacteria Product Picture
Figure 6. Insects Cell Culture Product Picture
Figure 7. Transgenics Product Picture
Figure 8. Global Biologic Therapeutics Drugs Market Share by Application in 2021 & 2028
Figure 9. Rheumatoid Arthritis
Figure 10. Anemia
Figure 11. Cancer
Figure 12. Diabetes
Figure 13. Others
Figure 14. Global Biologic Therapeutics Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Biologic Therapeutics Drugs Market Size (2017-2028) & (US$ Million)
Figure 16. Global Biologic Therapeutics Drugs Sales (2017-2028) & (K Units)
Figure 17. Biologic Therapeutics Drugs Sales Share by Manufacturers in 2021
Figure 18. Global Biologic Therapeutics Drugs Revenue Share by Manufacturers in 2021
Figure 19. The Global 5 and 10 Largest Biologic Therapeutics Drugs Players: Market Share by Revenue in 2021
Figure 20. Biologic Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 21. Global Biologic Therapeutics Drugs Sales Market Share by Region (2017-2022)
Figure 22. Global Biologic Therapeutics Drugs Sales Market Share by Region in 2021
Figure 23. Global Biologic Therapeutics Drugs Revenue Market Share by Region (2017-2022)
Figure 24. Global Biologic Therapeutics Drugs Revenue Market Share by Region in 2021
Figure 25. U.S. Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Canada Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Germany Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. France Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. U.K. Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Italy Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Russia Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Japan Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. South Korea Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. India Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Australia Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Taiwan Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Indonesia Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Thailand Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Malaysia Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Philippines Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Vietnam Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Mexico Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Brazil Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Argentina Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Turkey Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. Saudi Arabia Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 48. U.A.E Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 49. Sales Market Share of Biologic Therapeutics Drugs by Type (2017-2022)
Figure 50. Manufacturing Cost Structure of Biologic Therapeutics Drugs
Figure 51. Manufacturing Process Analysis of Biologic Therapeutics Drugs
Figure 52. Biologic Therapeutics Drugs Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’